Endoscopic management of biliary tract disease

Current Opinion in Gastroenterology

Volumn 15, Issue 5, 1999, Pages 448-453

  Pfau, Patrick R ^a   Kochman, Michael L ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILIARY TRACT DISEASE; BILIARY TRACT ENDOSCOPY; COMMON BILE DUCT STONE; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; ENDOSCOPIC THERAPY; EXTRACORPOREAL LITHOTRIPSY; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; OBSTRUCTIVE JAUNDICE; PANCREAS DISEASE; STENT;

EID: 0032769050     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199909000-00013     Document Type: Article

References (47)

1. 1 Cotton PB: Endoscopic management of bile duct stones. Gut 1984, 25:587-597.
2. 2 Vaira D, D'Anna L, Ainley C, Dowselt J, Williams S, Baillie J, Crohcn J, Cotton PB, Hatfield A: Endoscopic sphincterotomy in 1000 consecutive patients. Lancet 1989, ii:431-434.
3. 3 Lai ECS, Mok FPT, Tan ESY, Lo CM, Fan ST, You KT, Wong J: Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med 1992, 326:1582-1586.
4. 4 Cotton PB, Chung SC, Davis WZ, Gibson RM, Ransohoff DF, Strasberg SM: Issues in cholecystectomy and management of duct stones. Am J Gastroenterol 1994, 89:S169-176.
5. 5 Cotton PB, Geenen JE, Sherman S, Cunningham JT, Howell DA, CarrLocke DL, Nickl NJ, Hawes RH, Lehman GA, Ferrari A, Slivka A, Lichtenstein DR, Baillie J, Jowell PS, Lail LM, Evangelou H, Bosco JJ, Hanson BL, Hoffman BJ, Rahaman SM, Male R: Endoscopic sphincterotomy for stones is safe, even in younger patients with normal ducts, Ann Surg 1998, 227:201-204. Endoscopic sphincterotomy was performed in 1921 cases with an overall complication rate of 5.8%. The majority of complications were mild, requiring less than 3 days of hospitalization. Complication rates were lower for patients with normal bile ducts (< 9 mm) and age less than 60 years.
6. 6 Sherman S, Ruffolo TA, Hawes RH, Lehman GA: Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology 1991, 101:1068-1075.
7. 7 Pereira-Lima JC, Jakobs R, Winter UH, Benz C, Martin WR, Adamek HE, Riemann JF: Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence of biliary symptoms. Gastrointest Endosc 1998, 48:457-464, Two hundred three patients who underwent a sphincterotomy for choledocholithiasis were followed for a mean of 6.2 years. Fifteen percent had recurrent biliary symptoms. The gallbladder left in situ and choledochal diameter were risk factors for recurrent symptoms, while duct size and presence of a periampullary diverticulum were risk factors for recurrent stones.
8. 8 Sugiyama M, Atomi Y: Follow-up of more than 10 years after endoscopic sphincterotomy for choledocholithiasis. Br J Surg 1998, 85:917-921. One hundred three patients undergoing an ES for choledocholithiasis were followed for a mean of 14.2 years. Late complications including stone recurrence, cholangitis, and cholecystitis occurred in 9.7% of patients.
9. 9 Tanaka M, Takahata S, Konomi H, Matsunaga H, Yokohata K, Takeda I, Utsunomiya N, Ikeda S: Long-term consequence of endoscopic sphincterotomy for bile duct stones. Gastrointest Endosc 1998, 48:465-469. Four hundred ten patients who underwent an ES for choledocholithiasis were followed for a mean of 122 months. Stone recurrence-invariably of bilirubinate type-occurred in 12.3% of patients, suggesting that ablation of the sphincter might have a causative role in recurrent stones and symptoms.
10. 10 Choudhuri G, Sharrna BC, Saraswat VA, Argawal DK, Baijal SS: Biliary stenting for management of common bile duct stones. J Gastroenterol Hepatol 1998, 13:594-597.
11. 11 Chan ACW, Ng EKW, Chung SCS, Lai CW, Lau JYW, Sung JJY, Leung JWC, Li AKC: Common bile duct stones become smaller after endoscopic biliary stenting. Endoscopy 1998, 30:356-359.
12. 12 Chung SCS, Leung JWC, Leong HT, Li AKC: Mechanical lithotripsy of large common duct stones using a basket. Br J Surg 1991, 78:1448-1450.
13. 13 Neuhaus H, Zillinger C, Born P, Ott R, Allescher H, Rosch T, Classen M: Randomized study of intracorporeal laser lithotripsy versus extracorporeal shock-wave lithotripsy for difficult bile duct stones. Gastrointest Endosc 1998, 47:327-334.
14. 14 Neoptolemos JA, Carr Locke DL, Fossard DP: Prospective randomized study of preoperative endoscopic sphincterotomy versus surgery alone for common bile duct stones. Br Med J 1987, 294:470-474.
15. 15 Neoptolemos JA, Steigman G, Goff J; Precholecystectomy endoscopic cholangiography and stone removal is not superior to cholecystectomy, cholangiography, and common duct exploration. Am J Surg 1992, 163:227-230.
16. 16 Ponchon T, Bory R, Chavaillon A: Biliary lithiasis: combined endoscopic and surgical treatment. Endoscopy 1989, 21:15-18.
17. 17 Heinerman M, Boeckl O, Dimple W; Selective ERCP and preoperative stone removal in bile duct surgery. Ann Surg 1989, 209:267-272.
18. 18 Steigman G, Pearlman NW, Goff JS: Endoscopic cholangiography and stone removal prior to cholecystectomy. Arch Surg 1989, 124:787-790.
19. 19 Schumacher B, Freiling T, Haussinger D, Niederau C: Endoscopic treat-ment of symptomatic choledocholithiasis. Hepato-Gastroenterology 1998, 45:672-676. Two hundred seventeen patients with symptomatic choledocholithiasis were evaluated for successful clearance of stones and complication rate. Successful clearance was achieved in 98% of cases with no mortality and a 5% complication rate. This compares favorably to laparoscopic surgery, which has an 86.4% clearance and a 10.1% complication rate.
20. 20 Soehendra N, Seifert H, Thonke F, Seitz U, Wang YG: Endoscopic techniques for the therapy of choledocholithiasis. Chirurg 1994, 65:413-417.
21. 21 Grahm SM, Flowers JL, Scott TR: Laparoscopic cholecystectomy and common bile duct stones. Ann Surg 1993, 218:61-67.
22. 22 Sharma BC, Agarwal DK, Baijal SS, Saraswat VA, Choudhuri G, Naik SR: Endoscopic management of acute calculous cholangitis. J Gastroenterol Hepatol 1997, 12:874-876.
23. 23 Sugiyama M, Atomi Y: The benefits of endoscopic nasobiliary drainage without sphincterotomy for acute cholangitis. Am J Gastroenterol 1998, 93:2065-2068.
24. 24 Prat F, Tennenbaum R, Ponsot P, Altman C, Pelletier G, Fritsch J, Choury A, Bernades P, Etienne J: Endoscopic sphincterotomy in patients with liver cirrhosis. Gastrointest Endosc 1996, 43:127-131.
25. 25 Folsch UR. Nitsche R, Ludtke R, Hilgers RA, Crcutzfeldt W: Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. N Engl J Med 1997, 336:237-241.
26. 26 Neoptolemos JP, Carr-Locke DL, London NJ, Bailey IA, James D, Fossard DP: Controlled trial of urgent endoscopic retrograde cholangiopancreafography and endoscopic sphincterotomy versus conservative treatment tor acute pancreatitis due to gallstones. Lancet 1988, 2:979-983.
27. 27 Fan ST, Lai ECS, Mok FPT, Lo CM, Wong J: Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med 1993, 328:228-232.
28. 28 I'arnasky PR, Cotton PB: Early ERCP and papillotomy for acute biliary pancreatitis. N Engl J Med 1997, 336:1835-1036.
29. 29 Baillie J: Treatment of acute biliary pancreatitis. N Engl J Med 1997, 336:286-287.
30. 30 Ziebert JJ, Bjorkman D: Early ERCP in biliary pancreatitis: a macho mistake? Am J Gastroenterol 1998, 93:477-478.
31. 31 Pasricha P: Of opie, opossums, and others: emergent ERCP for gallstone pancreatitis. Gastroenterology 1997, 113:1040-1042.
32. 32 Chang L, Simon KL, Stabile BE, Lewis RJ, Virgilio C: Gallstone pancreatitis: a prospective study on the incidence of cholangitis and clinical predictors of retained common bile duct stones. Am J Gastroenterol 1998, 93:527-531. Three percent of 122 patients presenting with acute gallstone pancreatitis had concurrent cholangitis. Of the remaining patients 21% were found to have persistent CBD stones at a mean of 6.8 days after presentation with total bilirubin, ALT, and alkaline phosphatase levels being the best clinical predictors of retained stones.
33. 33 Ell C, Rabenstein T, Schneider HI, Ruppert T, Nicklas M, Bulling D: Safety and efficacy of pancreatic sphincterotomy in chronic pancreatitis. Gastrointest Endosc 1998, 48:244-248.
34. 34 Elton E, Howell DA, Parsons WG, Qasecm T, Hanson BL: Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique, Gastrointest Endosc 1998, 47:240-249. Pancreatic sphincterotomies performed on 160 patients were found to be safe with a 1.8% complication rate but a significantly higher complication rate if concomitant pancreatic drainage was not performed with a stent or nasopancreatic drain. Sphincterotomy was determined to be efficacious in 64% of patients when used as primary therapy and in 70% when used as an adjunct to other therapeutic interventions.
35. 35 Canto MIF, Chak A, Stellato T, Sivak MV: Endoscopic ulfrasonography versus cholangiography for the diagnosis of choledocholithiasis. Gastrointest Endosc 1998, 47:439-448. Sixty-four patients with suspected choledocholithiasis underwent evaluation with both ERCP and EUS in a blinded fashion. EUS and ERCP success rates (98% vs 94%) and accuracy (94% vs 97%) were equivalent. The complication rate was significantly lower with EUS, and EUS was a more cost-effective strategy in patients with a low to moderate risk of having CBD stones.
36. 36 Ledinghen V, Lecesne R, Raymond J, Gense V, Amouretti M, Drouillard J, Couzigou P, Silvain C: Diagnosis of choledocholithiasis: EUS or magnetic resonance cholangiography? A prospective controlled study. Gastrointest Endosc 1999, 49:26-31.
37. 37 Sugiyama M, Atomi Y: Acute biliary pancreatitis: the roles of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography. Surgery 1998, 124:14-21. Thirty-five patients with suspected acute biliary pancreatitis underwent transabdominal ultrasound, abdominal CT, ERCP, and EUS. EUS and ERCP both had a sensitivity of 100% for identifying CBD stones. EUS was able to identify further pancreatic pathology and had a 0% complication rate. The authors suggested EUS be used for diagnosis in acute biliary pancreatitis with ERCP limited to therapeutic cases where stones are identified.
38. 38 Smith AC, Dowsett JF, Russell RCG, Hatfield ARW, Cotton PB: Randomized trial of endoscopic stenting versus operative bypass in malignant obstructive jaundice. Lancet 1994, 344:1655-1660.
39. 39 Raikar GV, Melin MM, Ress A, Lettieri SZ, Poterucha JJ, Nagorney DM: Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer. Ann Surg Oncol 1996, 3:470-475.
40. 40 Ballinger AB, McHugh M, Catnach SM, Alstead EM, Clark MI: Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994, 35:467-470.
41. 41 Davids PHP, Groen AK, Rauws EAJ, Tytgat GNJ, Huibregste K: Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992, 340:1488-1492.
42. 42 Siegel JH, Pullano W, Kodsi B, Cooperman A, Ramsey W: Optimal palliation of malignant bile duct obstruction: experience with endoscopic 12 French prosthesis. Endoscopy 1988, 340:137-141.
43. 43 van Berkel AM, Boland C, Redekop WK, Bergman JJ, Groen AK, Tytgat GNJ, Huibregtse K: A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction, Endoscopy 1998, 30:681-686.
44. 44 Coene PPLO, Groen AK, Cheng J, Out MMJ, Tytgat GNJ, Huibregste K: Clogging of biliary endoprosthesis: a new prospective. Gut 1990, 31:913-917.
45. 45 Shim CS, Lee YH, Cho YD, Bong HK, Kim JO, Cho JY, Kim YS, Lee JS, Lee MS, Hwang SG, Shin KM: Preliminary results of a new covered biliary metal stent for malignant biliary obstruction. Endoscopy 1998, 30:345-349.
46. 46 Carr-Locke DL, Ball TJ, Connors PJ: Multicenter randomized trial of Wallstent biliary ondoprosthesis versus plastic stents. Gastrointest Endosc 1993, 39:A310.
47. 47 Iham TCK, Carr-Locke DL, Vandervoort J, Wong RCK, Lichtenstein DR, Van Dam J, Ruymann F, Chow S, Bosco JJ, Qaseem T, Howell D, Pleskow D, Vannerman W, Libby ED: Management of occluded biliary Wallstents. Gut 1998, 42:703-707. Endoscopic management of occluded metal self-expanding biliary stents is compared in 44 occluded stents. Initial resolution of obstruction was found in 98% of cases but no significant difference in patency rates was seen when comparing placement of a second Wallstent (75 days), insertion of a plastic stent (90 days) or mechanical clearing of the original stent (34 days). The most cost-effective strategy was placement of a plastic stent.